Revolution Medicines schedules call on pancreatic cancer trial results
Go back to Revolution Medicines schedules call on pancreatic cancer trial results| (NASDAQ: RVMD) | Delayed: 166.00 +3.01 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $162.99 | 52 Week High | $ | |||
| Open | $162.32 | 52 Week Low | $ | |||
| Day High | $166.23 | P/E | N/A | |||
| Day Low | $162.15 | EPS | $ | |||
| Volume | 367,238 | |||||

